最新ニュース Root (NASDAQ:ROOT) 株価情報

Root

Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. The company is a direct-to-consumer personal auto insurance, renters insurance and mobile technology company. It generates revenue from the sale of auto insurance policies within the United States.

Root Inc

Roots Corp

ROOT9B HOLDINGS INC by root9B Holdings, Inc.

root9B Holdings Inc

Biotech

Large Cap

News

Health Care

General

Health Canada Has Approved Merck's Keytruda (Pembrolizumab) For Adult Patients With Resectable Stage II, IIIA, or IIIB (T3-4N2) Non-Small Cell Lung Carcinoma In Combination With Platinum-Containing Chemotherapy As Neoadjuvant Treatment, And Then Continued As Monotherapy As Adjuvant Treatment After Surgery

VYGR

Voyager Therapeutics Announced It Has Decided To Assess Alternate Payloads Related To Its Gene Therapy Program For Superoxide Dismutase 1 (SOD1) Amyotrophic Lateral Sclerosis (ALS)

<h3>Gainers</h3>
<ul>
<li>BJ's Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJRI#NASDAQ">BJRI</a>) stock increased by 24.2% to $43.99 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.0 billion. </li>
<li>China Liberal Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLEU#NASDAQ">CLEU</a>) shares rose 20.27% to $0.13. The market value of their outstanding shares is at $35.1 million. </li>
<li>Interactive Strength (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNR#NASDAQ">TRNR</a>) shares moved upwards by 16.99% to $1.79. The market value of their outstanding shares is at $2.4 million. </li>
<li>Springview Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPHL#NASDAQ">SPHL</a>) stock moved upwards by 11.41% to $2.05. The company's market cap stands at $23.5 million. </li>
<li>Jiuzi Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JZXN#NASDAQ">JZXN</a>) shares rose 10.76% to $3.6. The company's market cap stands at $32.5 million. </li>
<li>Lincoln Educational Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINC#NASDAQ">LINC</a>) stock rose 8.88% to $18.99. The market value of their outstanding shares is at $597.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>MGO Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGOL#NASDAQ">MGOL</a>) shares decreased by 25.1% to $0.52 during Tuesday's pre-market session. The company's market cap stands at $4.8 million. </li>
<li>PetMed Express (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PETS#NASDAQ">PETS</a>) shares declined by 21.45% to $4.14. The market value of their outstanding shares is at $85.5 million. The company's, Q3 earnings came out yesterday. </li>
<li>Hour Loop (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOUR#NASDAQ">HOUR</a>) shares declined by 12.29% to $2.0. The market value of their outstanding shares is at $70.2 million. </li>
<li>Damon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMN#NASDAQ">DMN</a>) shares decreased by 9.18% to $0.49. The company's market cap stands at $10.7 million. </li>
<li>SRM Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRM#NASDAQ">SRM</a>) shares fell 7.24% to $0.29. The market value of their outstanding shares is at $4.6 million. </li>
<li>Youdao (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAO#NYSE">DAO</a>) shares fell 7.21% to $10.3. The company's market cap stands at $1.2 billion. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

BJRI

CLEU

HOUR

JZXN

LINC

MGOL

PETS

SPHL

TRNR

12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Lipella Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIPO#NASDAQ">LIPO</a>) stock moved upwards by 64.9% to $5.03 during Tuesday's pre-market session. The company's market cap stands at $6.0 million. </li>
<li>Ocean Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCEA#NASDAQ">OCEA</a>) stock moved upwards by 50.47% to $0.22. The market value of their outstanding shares is at $7.7 million. </li>
<li>Third Harmonic Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRD#NASDAQ">THRD</a>) stock increased by 20.21% to $5.59. The market value of their outstanding shares is at $251.8 million. </li>
<li>Lixte Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIXT#NASDAQ">LIXT</a>) stock increased by 15.78% to $2.64. The company's market cap stands at $5.9 million. </li>
<li>Silexion Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) shares increased by 15.26% to $1.51. The market value of their outstanding shares is at $6.0 million. </li>
<li>CNS Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) shares rose 10.53% to $0.11. The company's market cap stands at $6.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Prelude Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRLD#NASDAQ">PRLD</a>) shares fell 17.4% to $0.9 during Tuesday's pre-market session. The market value of their outstanding shares is at $49.5 million. </li>
<li>Stoke Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STOK#NASDAQ">STOK</a>) shares declined by 11.3% to $9.11. The market value of their outstanding shares is at $482.5 million. </li>
<li>DIH Holding US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DHAI#NASDAQ">DHAI</a>) stock decreased by 10.75% to $0.61. The market value of their outstanding shares is at $21.5 million. </li>
<li>Biodexa Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDRX#NASDAQ">BDRX</a>) stock declined by 10.62% to $4.8. The market value of their outstanding shares is at $3.2 million. </li>
<li>Invivyd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVVD#NASDAQ">IVVD</a>) shares fell 9.56% to $1.42. The market value of their outstanding shares is at $169.8 million. </li>
<li>Avinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) stock declined by 9.0% to $0.44. The company's market cap stands at $1.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AVGR

BDRX

CNSP

DHAI

IVVD

LIPO

LIXT

OCEA

PRLD

SLXN

STOK

THRD

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Regeneron Pharmaceuticals, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the resubmission of the Biologics License Application (BLA) for linvoseltamab for the treatment of adult patients with relapsed/refractory (R/R) multiple myeloma (MM) who have received at least four prior lines of therapy or those who received three prior lines of therapy and are refractory to the last line of therapy. The target action date for the FDA decision is July 10, 2025.
Acceptance of the BLA resubmission follows the resolution of third-party fill/finish manufacturing issues, which was the sole approvability issue identified by the FDA in the previous submission. The BLA is supported by data from the pivotal <a href="https://www.globenewswire.com/Tracker?data=032VzgfH3Zwknll4UBWp8zhL6nLWeVfQ1uAUbAV9jnbajCy8FTsCvmUFAcFkm2eV2t8IsNs_EENj37PPYz-UlBqu0UDpGan2Fb0QI2pnGVLOoY0TTAijCF94frYMM2vmpGyaZQXMcarXAK7CoIb_u_KN_JrMo6DgxNNL8nroMNCP8WxgVYfRst4Y4E16DQxgOhjw4zyPn14Rb0E4YfjvaA==">LINKER-MM1</a> trial investigating linvoseltamab in R/R MM, and linvoseltamab is also under <a href="https://www.globenewswire.com/Tracker?data=VbdWV_4JC1drSn1toq6OXZrfe0cN2O7_-1sX29HBZEhwCraOE4NHWui62si87wvGd_evR2y4lyNT3suHRjq5Unu5_dIpapz8ZNlk4DAEdaql_zXgO3uLdRsY7W_5_Qh1i4ibQb8-BPGiH7K1yDxOsY3Mq-p-i3oU-iiMXVErUzjEtQlvuxgmzOjmgqrPDBM6FoGMQDUJhRnDgmdZPq7OZw==">review</a> by the&nbsp;European Medicines Agency (EMA) for the same patient population.
Linvoseltamab is investigational and has not been approved by any regulatory authority.

Government

Regulations

REGN

Regeneron Clears Manufacturing Hurdle as FDA Sets July 2025 Decision Date for Linvoseltamab in Multiple Myeloma

<h3>Gainers</h3>
<ul>
<li>Vast Renewables (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTE#NASDAQ">VSTE</a>) shares moved upwards by 46.4% to $1.01 during Tuesday's pre-market session. The market value of their outstanding shares is at $30.2 million. </li>
<li>Rain Enhancement (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAIN#NASDAQ">RAIN</a>) shares moved upwards by 17.64% to $3.8. The company's market cap stands at $28.7 million. </li>
<li>Universal Logistics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULH#NASDAQ">ULH</a>) shares rose 16.85% to $34.74. The company's market cap stands at $914.2 million. As per the news, the Q4 earnings report came out 3 days ago. </li>
<li>Elong Power Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELPW#NASDAQ">ELPW</a>) stock moved upwards by 8.08% to $1.07. The company's market cap stands at $53.5 million. </li>
<li>Satellogic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATL#NASDAQ">SATL</a>) stock increased by 7.76% to $4.86. The company's market cap stands at $465.5 million. </li>
<li>Quanex Building Prods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NX#NYSE">NX</a>) stock moved upwards by 6.51% to $22.89. The company's market cap stands at $1.0 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Fluence Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) shares declined by 38.0% to $8.1 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.0 billion. The company's, Q1 earnings came out yesterday. </li>
<li>New Century Logistics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCEW#NASDAQ">NCEW</a>) shares declined by 21.49% to $1.06. The market value of their outstanding shares is at $22.7 million. </li>
<li>Momentus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNTS#NASDAQ">MNTS</a>) stock fell 10.42% to $4.0. The company's market cap stands at $11.1 million. </li>
<li>Columbus McKinnon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCO#NASDAQ">CMCO</a>) shares declined by 8.55% to $32.45. The company's market cap stands at $930.9 million. As per the news, the Q3 earnings report came out yesterday. </li>
<li>FBS Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBGL#NASDAQ">FBGL</a>) stock decreased by 7.0% to $1.33. The company's market cap stands at $17.9 million. </li>
<li>Samfine Creation Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFHG#NASDAQ">SFHG</a>) shares fell 6.85% to $0.9. The market value of their outstanding shares is at $20.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CMCO

ELPW

FBGL

FLNC

MNTS

NCEW

RAIN

SATL

SFHG

VSTE

12 Industrials Stocks Moving In Tuesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) shares moved upwards by 38.4% to $0.26 during Tuesday's pre-market session. The market value of their outstanding shares is at $5.4 million. </li>
<li>Lattice Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) stock rose 14.3% to $62.26. The company's market cap stands at $8.5 billion. As per the press release, Q4 earnings came out yesterday. </li>
<li>Bit Origin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTOG#NASDAQ">BTOG</a>) shares moved upwards by 10.04% to $0.54. The market value of their outstanding shares is at $4.5 million. </li>
<li>UTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) stock rose 9.35% to $0.29. The company's market cap stands at $7.4 million. </li>
<li>Perfect (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PERF#NYSE">PERF</a>) shares rose 7.98% to $2.3. The company's market cap stands at $234.2 million. </li>
<li>Glimpse Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAR#NASDAQ">VRAR</a>) shares rose 7.34% to $1.9. The company's market cap stands at $38.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Harmonic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) shares decreased by 27.4% to $8.07 during Tuesday's pre-market session. The company's market cap stands at $940.3 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Brand Engagement Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>) stock declined by 18.72% to $0.56. The company's market cap stands at $21.4 million. </li>
<li>Viasat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSAT#NASDAQ">VSAT</a>) shares decreased by 16.84% to $9.29. The market value of their outstanding shares is at $1.1 billion. As per the news, the Q3 earnings report came out 3 days ago. </li>
<li>Socket Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCKT#NASDAQ">SCKT</a>) shares declined by 13.48% to $1.22. The company's market cap stands at $9.2 million. </li>
<li>Amkor Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) stock fell 9.49% to $22.05. The market value of their outstanding shares is at $5.4 billion. The company's, Q4 earnings came out yesterday. </li>
<li>Cloudastructure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSAI#NASDAQ">CSAI</a>) stock decreased by 8.68% to $11.27. The company's market cap stands at $164.4 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMKR

BNAI

BTOG

CSAI

HLIT

LSCC

PERF

SCKT

VRAR

VSAT

12 Information Technology Stocks Moving In Tuesday's Pre-Market Session

Third Harmonic Bio Says THB335 Phase 1 Data Supports Advancement Into Phase 2 Clinical Trial In Chronic Spontaneous Urticaria (CSU)

Distribution
On January 27, 2025, the Board of Directors of SUN's general partner declared a distribution for the fourth quarter of 2024 of $0.8865 per unit, or $3.5460 per unit on an annualized basis. The distribution will be paid on February 19, 2025, to common unitholders of record on February 7, 2025.
The Partnership is targeting a distribution growth rate of at least 5% for 2025 and will announce future increases quarterly.

Dividends

Sunoco Targets Distribution Growth Rate Of At Least 5% For 2025 And Will Announce Future Increases Quarterly

Needham analyst Joseph Stringer reiterates Vertex Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) from Hold to Hold.

Reiteration

Analyst Ratings

VRTX

Needham Reiterates Hold on Vertex Pharmaceuticalsto Hold

Guidance

Masco Sees FY25 Adj. EPS Of $4.20 - $4.45 Vs. $4.40 Est.

<ul>
<li>Revenue to grow at a mid-twenties percentage rate on a year-over-year basis;</li>
<li>Gross profit dollars to grow at a low-twenties percentage rate on a year-over-year basis;</li>
<li>Operating expense as a percentage of revenue to be 41% to 42%;</li>
<li>Stock-based compensation to be $120 million; and</li>
<li>Free cash flow margin to be in the mid-teens.</li>
</ul>

SHOP

Shopify Sees Q1 2025 Revenue Growth Mid-Twenties Percentage Rate On YoY Basis

Subject to the finalization of financial reporting processes, including the finalization of income taxes, net income for the fourth quarter of 2024 is expected to be between $31 million and $37 million, compared to a net loss of $12 million in the fourth quarter of 2023.
 &nbsp;

PSFE

Paysafe Expects Q4 Revenue To Be $420M (Est $437.54M), Up 1% YoY, Or 4% When Excluding The Disposed Business

Earnings

ARVN

Arvinas Says Its Cash, Cash Equivalents, And Marketable Securities Of $1.04B As Of December 31, 2024, Is Sufficient To Fund Planned Operating Expenses And Capital Expenditure Requirements Into 2027

WIIM

Marriott shares are trading lower following soft Q1 guidance.

<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="4">Summary of First Quarter 2025 Guidance (Unaudited, in millions, except per share amounts)(1)</td>
</tr>
<tr>
<td>IFRS</td>
<td>Share-based compensation</td>
<td>Non-IFRS (2)</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Net revenue</td>
<td>$1,550 - $1,600</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Gross profit</td>
<td>$325 - $370</td>
<td>$14 - $16</td>
<td>$341 - $384</td>
</tr>
<tr>
<td>Gross margin(3) (mid-point)</td>
<td>22.1%</td>
<td>23.0%</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Operating profit</td>
<td>$94 - $167</td>
<td>$47 - $57</td>
<td>$151 - $214</td>
</tr>
<tr>
<td>Operating margin(3) (mid-point)</td>
<td>8.3%</td>
<td>11.6%</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Net income (4)</td>
<td>$78 - $142</td>
<td>$47 - $57</td>
<td>$135 - $189</td>
</tr>
<tr>
<td>Net income margin(3) (mid-point)</td>
<td>7.0%</td>
<td>10.3%</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Diluted EPS</td>
<td>$0.14 - $0.26</td>
<td>$0.24 - $0.34</td>
<td>&nbsp;</td>
</tr>
</tbody>
</table>
</figure>

GlobalFoundries Expects Q1 Revenue Of $1.55B-$1.60B Vs $1.66B Est, Adj EPS Of $0.24-$0.34 Vs $0.32 Est

Marriott Sees Q1 Adj. EPS $2.20-$2.26 vs $2.37 Est., RevPAR Growth 3%-4%; Sees FY25 Adj. EPS $9.82-$10.19 vs $10.65 Est., RevPAR Growth 2%-4%

Masco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAS#NYSE">MAS</a>) reported quarterly earnings of $0.89 per share which beat the analyst consensus estimate of $0.87 by 2.3 percent. This is a 7.23 percent increase over earnings of $0.83 per share from the same period last year. The company reported quarterly sales of $1.828 billion which missed the analyst consensus estimate of $1.835 billion by 0.36 percent. This is a 2.87 percent decrease over sales of $1.882 billion the same period last year.

Earnings Beats

Earnings Misses

Masco Q4 2024 Adj. EPS $0.89 Beats $0.87 Estimate, Sales $1.828B Miss $1.835B Estimate

Ceragon Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNT#NASDAQ">CRNT</a>) reported quarterly earnings of $0.09 per share which met the analyst consensus estimate. This is a 125 percent increase over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $106.932 million which beat the analyst consensus estimate of $105.176 million by 1.67 percent. This is a 18.34 percent increase over sales of $90.359 million the same period last year.

CRNT

Ceragon Networks Q4 2024 Adj. EPS $0.09, Inline, Sales $106.932M Beat $105.176M Estimate

Sunoco Q4 2024 GAAP EPS $0.75 Misses $1.34 Estimate, Sales $5.269B Miss $6.212B Estimate

In a report released today, Elyse Greenspan from Wells Fargo maintained a Hold rating on Root (ROOT – Research Report), with a price target of $80....

Wells Fargo Sticks to Its Hold Rating for Root (ROOT)

Discover the top stock picks for today's risk-on market, driven by light PPI data and anticipation of CPI. This article provides a macro review, detailed analyses of key trades, and swing trade opportunities, including KTOS, NBIS, ROOT, and more.

Light PPI Sparks Optimism: Today's Must-Watch Stocks

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Shriram Finance Limited (IN:SHRIRAMFIN – Research R...

Analysts Conflicted on These Financial Names: Shriram Finance Limited (IN:SHRIRAMFIN) and Root (ROOT)

Given the growing demand for insurance products across varied segments and the growing adoption of advanced technology, the insurance industry is well-poised for continued solid growth. Hence, it could be wise to invest in top insurtech stocks CCC Intelligent Solutions (CCCS), Oscar Health (OSCR), and Root, Inc. (ROOT) which are reinventing insurance industry. Continue reading... The insurtech industry combines insurance operations with cutting-edge technologies like AI, ML, and IoT, offering consumers convenient and fair solutions and services. The insurtech segment is growing strongly and reinventing the $7 trillion insurance industry, including how its solutions are designed, delivered, and managed.
Given the industry's rapid evolution, investing in fundamentally strong insurtech stocks CCC Intelligent Solutions Holdings Inc. (<a href="https://stocknews.com/stock/CCCS/">CCCS</a>), Oscar Health, Inc. (<a href="https://stocknews.com/stock/OSCR/">OSCR</a>), and Root, Inc. (<a href="https://stocknews.com/stock/ROOT/">ROOT</a>) could be ideal investments in the upcoming year.
The insurance industry is rapidly evolving owing to the various factors that are reshaping the landscape. Robust economic growth, technological advancements, rising healthcare costs, demographic shifts, growing cyber risks, and evolving customer expectations are key contributors to this expansion.
Besides, the emergence of <a href="https://www.crai.com/insights-events/publications/overview-of-insurtech-companies-stock-performance-and-securities-class-action-filings/">Insurtech companies</a> has significantly revolutionized the market with the introduction of innovative technologies like artificial intelligence (AI), machine learning, the Internet of Things (IoT), big data, and blockchain. These innovative technologies have resulted in improved risk identification and mitigation measures, streamlined processes, and enhanced customer experience.
<a href="https://www.statista.com/outlook/fmo/insurances/united-states">Statista projects</a> that the insurance market in the United States will reach a market size (gross written premium) of $3.93 trillion in 2025. Further, the USA life &amp; non-life insurance market in terms of net written premiums value is anticipated to reach around <a href="https://www.mordorintelligence.com/industry-reports/life-non-life-insurance-market-in-usa">$3.02 trillion by 2030</a>, exhibiting growth at a CAGR of 6.9%.
Further, insurance companies are increasingly leveraging AI to optimize their operations, enhance customer experiences, and stay competitive in the market, resulting in robust growth of global <a href="https://www.precedenceresearch.com/artificial-intelligence-in-insurance-market">artificial intelligence (AI) in the insurance market</a>. The market is poised to reach $141.44 billion by 2034, expanding at a CAGR of 33.1%.
Considering this favorable backdrop, let's assess the fundamentals of the three insurtech stocks which are reinventing and revolutionizing the $7 trillion insurance industry.
CCC Intelligent Solutions Holdings Inc. (<a href="https://stocknews.com/stock/CCCS/">CCCS</a>)
CCCS operates as a software as a service company for the property and casualty insurance economy internationally. The company's cloud-based SAAS platform connects trading partners, facilitates commerce, and supports mission-critical, AI-enabled digital workflow across the insurance economy, including insurers, repairers, automakers, parts suppliers, lenders, and more.
On January 6, 2025, CCCS and its subsidiary completed the acquisition of EvolutionIQ, Inc., the leading platform for AI-powered guidance for disability and injury claims management. The strategic acquisition expanded CCCS' market reach into strategic adjacencies - disability and workers' compensation- and strengthened its SaaS platform with transformative AI capabilities.
The companies' combined strength of AI-based platforms will revolutionize claim resolution across the insurance economy.
On November 13, 2024, CCCS and Repairify, the global leader in remote diagnostics, calibrations, programming, and automotive intelligence, announced today a new integration between the ADAS-focused platform, adasThink, and CCC ONE&#xAE; software from CCCS.
The collaboration aims to provide collision repair shops with seamless access to advanced driver assistance systems insights, helping to enhance repair precision, increase efficiency, and reduce cycle times.
For the third quarter that ended September 30, 2024, CCCS' revenues grew 7.8% year-over-year to $238.48 million. The company's adjusted gross profit increased 8% from the year-ago value to $185.93 million. Its adjusted operating income came in at $91.19 million, up 10.3% from the prior year's quarter.
Furthermore, the company's adjusted net income was $62.58 million or $0.10, reflecting 9.5% and 11.1% year-over-year increases, respectively. Also, CCCS' <a href="https://www.investopedia.com/terms/a/adjusted-ebitda.asp">adjusted EBITDA</a> rose 9.3% from the prior year's period to $101.55 million.
CCCS issued its financial guidance for the fourth quarter and full-year fiscal 2024. The company expects revenue of $242.50 million to $246.5 million and adjusted EBITDA of $103 million - $105 million for the fourth quarter.
For the full fiscal year 2024, the company projects revenue between $ 941 million and $945 million. Its adjusted EBITDA is set between $ 394 million and $396.0 million.
Street expects CCCS' EPS for the fourth quarter (ended December 2024) to increase 8% year-over-year to $0.10, while its revenue for the same period is expected to grow 7.2% year-over-year to $245.09 million. Also, the company topped the consensus revenue and EPS estimates in each of the trailing four quarters, which is impressive.
Shares of CCCS have gained 4.2% over the past six months and 6.2% over the past year to close the last trading session at $11.70.
CCCS' robust outlook is reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, each weighted to an optimal degree.
CCCS has a B grade for Growth, Stability, and Sentiment. It is ranked #10 out of 18 stocks in the A-rated <a href="https://stocknews.com/category/software-saas/">Software - SAAS</a> industry.
In addition to the POWR Ratings I've just highlighted, you can see CCCS' Momentum, Value, and Quality ratings <a href="https://stocknews.com/stock/CCCS/">here</a>.
Oscar Health, Inc. (<a href="https://stocknews.com/stock/OSCR/">OSCR</a>)
OSCR is a health insurance company that offers health plans in individual and small group markets and provides reinsurance products. It also offers +Oscar, a technology-driven platform that helps providers and payors directly enable their shift to value-based care.
On November 15, 2024, OSCR introduced affordable health insurance products with Oscar experience, which empower individuals, families, and businesses through the ACA marketplace in New Jersey. This includes services built to meet personal needs and preferences, high-quality networks, and technology solutions.
Also, on November 4, 2024, OSCR entered the greater Charlotte and Winston-Salem areas of North Carolina and introduced the Oscar experience to individuals and families through the ACA marketplace in 2025.
For the nine months that ended September 30, 2024, OSCR's total revenue increased 53.1% year-over-year to $6.78 billion, and its earnings from operations was $ 205 million. The company's net income attributable to OSCR and EPS came in at $178.98 million and $0.65 for the period, respectively.
In addition, the company's adjusted EBITDA grew 370% from the year-ago period to $311.88 million.
Analysts expect OSCR's revenue and EPS for the first quarter (ending March 2025) to increase 30.3% and 2.4% year-over-year to $2.79 billion and $0.64, respectively. Moreover, the company has an impressive earnings surprise history as it surpassed the consensus EPS and revenue estimate in three of the trailing four quarters.
OSCR's shares have surged 20.4% over the past month and 47% over the past year to close the last trading session at $16.26.
OSCR's bright prospects are reflected in its POWR Ratings. The stock has a B grade for Value. Within the A-rated <a href="https://stocknews.com/category/health-insurance/">Medical - Health Insurance</a> industry, OSCR is ranked #9 out of 10 stocks.
<a href="https://stocknews.com/stock/OSCR/">Click here</a> to access additional OSCR ratings for Sentiment, Quality, Growth, Momentum, and Stability.
Root, Inc. (<a href="https://stocknews.com/stock/ROOT/">ROOT</a>)
ROOT offers insurance products and services. The company provides automobile, homeowners, and renters' insurance products. It operates a direct-to-consumer model and serves customers primarily through mobile applications and its website.
On December 17, 2024, ROOT introduced Root Insurance in Minnesota, marking its presence in over 35 states, offering an innovative approach to auto insurance to over 4 million registered drivers in Minnesota. The service expansion will provide drivers with a new option for fair, affordable prices that reflect their individual driving habits.
On September 5, 2024, ROOT partnered with First Connect Insurance Services, a digital platform designed to support independent agents. The partnership aims to offer API-powered quotes and binding capabilities to independent insurance agents. The interface streamlined access to ROOT's standard and preferred auto insurance for agents and expanded companies' offerings.
In the third quarter that ended September 30, 2024, ROOT's total revenue increased 5.7% from the prior quarter to $305.70 million. Its gross profit grew 39.5% from the quarter-ago value to $98.90 million. Also, the company's adjusted EBITDA rose 243.8% from the previous quarter to $41.60 million.
The company's net income and EPS were $22.80 million and $1.35 for the quarter, respectively.
Analysts expect ROOT's revenue for the fourth quarter (ended December 2024) to increase 47.7% year-over-year to $287.79 million. Likewise, the company's revenue for the fiscal year 2024 is estimated to grow 149.6% from the prior year to $1.14 billion. Also, it has topped the consensus revenue and EPS estimates in all four trailing quarters.
ROOT's stock has gained 14.3% over the past month and 790.1% over the past year to close the last trading session at $81.18.
ROOT's POWR Ratings reflect its promising outlook. The stock has an A grade for Momentum. It also has a B grade for Growth. ROOT is ranked #46 of 55 stocks within the A-rated <a href="https://stocknews.com/category/property-casualty-insurance/">Insurance - Property &amp; Casualty</a> industry.
To see additional POWR Ratings of ROOT for Value, Stability, Sentiment, and Quality, <a href="https://stocknews.com/stock/ROOT/">click here</a>.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
CCCS shares were trading at $11.49 per share on Thursday afternoon, down $0.21 (-1.79%). Year-to-date, CCCS has declined -2.05%, versus a 3.75% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Rjkumari Saxena</h2> <img src='https:/wp-content/uploads/2024/04/Rajkumari-Saxena_Image-1.jpeg' style="float:left; padding:5px;width:125px;">Rajkumari started her career as a writer but gradually shifted her focus to financial journalism, leveraging her educational background in Commerce. Fascinated by the interplay of business and economic shifts in equities, she aspires to evolve as an analyst. With a knack for simplifying complex financial concepts, her mission is to empower investors with insights that lead to profitable decisions.<a href="https://stocknews.com/authors/?author=rajkumari-saxena">More...</a>The post <a href=https://stocknews.com/news/cccs-oscr-root-3-insurtech-stocks-reinventing-the-7-trillion-insurance-industry/>3 InsurTech Stocks Reinventing the $7 Trillion Insurance Industry</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 InsurTech Stocks Reinventing the $7 Trillion Insurance Industry

ARBE

CCCS

KTOS

MIND

NBIS

OPFI

OSCR

PDYN

QUIK

ROOT

TDOC

TRUG

Press Releases

Root Insurance Partners with Goosehead Insurance to Simplify Insurance Sales for Independent Agents

Fintech

Insurance

First Connect and Root Launch Streamlined Quote & Bind Process for Independent Insurance Agents

Root, Inc. Schedules Conference Call to Discuss Third Quarter 2024 Financial Results

Financing

Root Announces Successful Refinancing of Term Loan Facility with BlackRock

Root, Inc. Announces 2024 Third Quarter Results

Root Insurance Expands to Minnesota, Offering Personalized, Driver-Based Rates

Root, Inc. to Participate in the 27th Annual ICR Conference

Root Insurance to Host Current and Future Partners at National Automobile Dealers Association Show in New Orleans

Root, Inc. Schedules Conference Call to Discuss 2024 Fourth Quarter and Full Year Financial Results

Root's Super Bowl Survey: Nearly Half of Football Fans Watched Games While Driving this Season

Comments

Root

ニュース

最新ニュース Root (NASDAQ:ROOT) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル